IRIS
CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.270
AS - Asia 5.137
NA - Nord America 3.360
SA - Sud America 1.430
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 21.297
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.388
US - Stati Uniti d'America 3.274
SG - Singapore 1.896
IE - Irlanda 1.303
BR - Brasile 1.183
CN - Cina 1.082
HK - Hong Kong 991
GB - Regno Unito 399
IT - Italia 369
VN - Vietnam 360
KR - Corea 347
DE - Germania 273
GR - Grecia 173
IN - India 151
AR - Argentina 96
FR - Francia 58
FI - Finlandia 56
EC - Ecuador 48
JP - Giappone 48
SE - Svezia 45
ID - Indonesia 44
BD - Bangladesh 38
UA - Ucraina 35
MX - Messico 34
TR - Turchia 33
AT - Austria 30
ZA - Sudafrica 30
CA - Canada 28
CO - Colombia 26
NL - Olanda 25
PL - Polonia 25
ES - Italia 21
IQ - Iraq 18
PK - Pakistan 18
PY - Paraguay 18
VE - Venezuela 18
BE - Belgio 17
MA - Marocco 17
PE - Perù 17
UZ - Uzbekistan 16
EG - Egitto 15
CZ - Repubblica Ceca 12
TH - Thailandia 11
KE - Kenya 10
CL - Cile 9
DZ - Algeria 9
KZ - Kazakistan 9
JM - Giamaica 8
UY - Uruguay 8
AE - Emirati Arabi Uniti 7
AZ - Azerbaigian 7
MY - Malesia 7
NP - Nepal 7
RS - Serbia 7
TW - Taiwan 7
CH - Svizzera 6
SA - Arabia Saudita 6
BO - Bolivia 5
JO - Giordania 4
MK - Macedonia 4
OM - Oman 4
PA - Panama 4
PT - Portogallo 4
TN - Tunisia 4
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
IL - Israele 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
EE - Estonia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LT - Lituania 2
NG - Nigeria 2
NO - Norvegia 2
PH - Filippine 2
RO - Romania 2
SN - Senegal 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GL - Groenlandia 1
GT - Guatemala 1
GY - Guiana 1
LB - Libano 1
Totale 21.289
Salva come PNG Salva come JPEG
Città #
Moscow 2.719
Dublin 1.302
Santa Clara 1.008
Hong Kong 979
Singapore 655
Jacksonville 398
Seoul 344
Hefei 257
Princeton 187
Roxbury 187
Chandler 176
Beijing 146
Medford 140
Ho Chi Minh City 130
Bremen 121
Bengaluru 90
Ashburn 88
São Paulo 88
Naples 82
Hanoi 75
New York 66
Des Moines 61
Dallas 52
Ann Arbor 51
Cambridge 50
Boardman 47
Munich 46
The Dalles 44
Wilmington 41
Jinan 37
Los Angeles 36
Rio de Janeiro 33
Rome 32
Nanjing 27
Nuremberg 25
Belo Horizonte 24
Falkenstein 24
Turku 23
Curitiba 22
Guarulhos 22
Boston 21
Dearborn 20
Guayaquil 20
Brasília 19
Da Nang 19
Guangzhou 17
Porto Alegre 17
Hebei 16
Lappeenranta 16
Campinas 15
Haiphong 15
Shenyang 15
Buenos Aires 14
Caserta 14
Chennai 14
Johannesburg 14
Tashkent 14
Tokyo 14
Amsterdam 13
Brussels 13
Vienna 13
Goiânia 12
Helsinki 12
Jakarta 12
Palermo 12
Salvador 12
Shanghai 12
Warsaw 12
Ninh Bình 11
Norwalk 11
Ribeirão Preto 11
São José dos Campos 11
Atlanta 10
Bangkok 10
Biên Hòa 10
Lima 10
London 10
Redwood City 10
Tianjin 10
Bogotá 9
Brno 9
Frankfurt am Main 9
Havertown 9
Hải Dương 9
Milan 9
Montreal 9
Pune 9
Recife 9
San Francisco 9
Santo André 9
São Gonçalo 9
Casablanca 8
Caxias do Sul 8
Changsha 8
Manaus 8
Nairobi 8
Nanchang 8
Pamplona 8
Praia Grande 8
Quito 8
Totale 10.646
Salva come PNG Salva come JPEG
Nome #
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 159
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 152
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 137
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 137
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 136
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 132
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 127
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 125
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 123
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 122
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 121
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 121
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 119
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 118
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 118
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 116
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 113
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 110
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 110
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 110
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 110
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 109
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 109
CD8+tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade 107
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 105
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 105
Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery 104
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 103
ILC3 in Axial Spondyloarthritis: the Gut Angle 103
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 101
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 101
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 101
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 101
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 101
Precision medicine in systemic lupus erythematosus 100
Gut dysbiosis in Spondyloarthritis: Cause or effect? 100
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 99
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 98
New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? 98
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 98
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 98
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 97
Adult-onset Still's disease with elderly onset: results from a multicentre study 97
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 96
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 96
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 95
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease 94
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 93
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 93
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 93
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe? 92
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 92
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity 92
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 91
Interstitial lung disease in systemic sclerosis: current and future treatment 91
Gut inflammation in spondyloarthritis 91
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 91
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 91
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 90
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 90
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 90
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 90
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 89
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 89
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 89
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 89
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 88
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 87
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 87
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 87
Autophagy in the pathogenesis of ankylosing spondylitis 87
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 87
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 87
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 87
JAK/STAT Pathway Targeting in Primary Sjögren Syndrome 87
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 86
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 86
The Cross-Talk between Microbiome and Metabolome in Rheumatoid Arthritis 86
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 86
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 86
Erratum: IL-33 is overexpressed in the inflamed arteries of patients with giant cell arteritis (Annals of the Rheumatic Diseases (2013) 72 (258-64)) 85
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 85
Intestinal Involvement in Kawasaki Disease 85
Cardiovascular disease in primary sjögren’s syndrome 85
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 85
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 85
The gut-enthesis axis and the pathogenesis of Spondyloarthritis 84
Rituximab modulates the expression of IL-22 in the salivary glands of patients with primary Sjogren's syndrome 84
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity 84
The role of the gastrointestinal tract in the pathogenesis of rheumatic diseases 84
T2-mapping of the sacroiliac joints at 1.5 Tesla: a feasibility and reproducibility study 84
The craniovertebral junction in rheumatoid arthritis: State of the art 84
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 83
Intestinal dysbiosis and innate immune responses in axial spondyloarthritis 82
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 82
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 82
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 82
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis 82
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 82
Assessment of health-related quality of life in patients with adult onset Still disease: Results from a multicentre cross-sectional study 81
Totale 9.842
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.074
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.074
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021408 0 0 0 0 0 6 146 12 39 16 181 8
2021/20221.010 21 11 1 24 372 4 37 16 48 28 66 382
2022/20231.724 246 12 26 17 208 59 4 60 1.020 5 43 24
2023/20241.034 35 30 39 55 368 101 27 29 11 7 57 275
2024/20254.258 14 46 10 88 650 520 482 441 540 943 305 219
2025/202612.442 546 868 899 968 1.271 7.890 0 0 0 0 0 0
Totale 21.827